INGN
Inogen, Inc.Healthcare · $143M market cap
Verdict
We can't put a fair value on INGN right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow INGN
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 1, 2026: no open-market purchases and 5 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
Smith Kevin Raymond Merrill
CEO and President · 2026-09-01
Award
$8K
Smith Kevin P.
EVP, Bus Dev, GC & Sec · 2026-09-01
Tax withholding
$46K
Smith Kevin P.
EVP, Bus Dev, GC & Sec · 2026-09-01
Option exercise
18,136 shares
Smith Kevin P.
EVP, Bus Dev, GC & Sec · 2026-09-01
Award
$8K
Wright Mary E
VP, Chief Accounting Officer · 2026-09-01
Award
$8K
About Inogen, Inc.
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works